The Neurotechnology Industry 2008 Report

Published by: NeuroInsights, LLC

Published: May. 8, 2008 - 392 Pages

Table of Contents

1: Executive Summary

The Brain Industry Revealed

Investment Risks and Opportunities

Neurotechnology and Society

Key Industry Facts and Findings

Timeline of Advances in Neuroscience

2: Trends and Drivers

Converging Technologies

Stem Cells and Neuroregeneration

Neuroimaging, Diagnostics, and Disease Treatment

Crossing the Blood Brain Barrier

Demographic Drivers

More People Living Longer

Social Drivers

The Life Style Improvement Market

Economic Drivers

Worldwide Economic Burden

Rising Healthcare Costs

Research Funding

United States Government

International Research Funding

Foundations Focus on the Brain

Regulatory Trends

International Regulatory Competition

Intellectual Property Trends

Global Intellectual Property Protection

Neuropharmaceutical Patent Expirations

Patent Activity in the US: 1980-2007

Selected Neurotechnology Patents

3: Neuropharmaceutical Sector

Neuropharmaceutical Sector Overview

Trends in Neuropharmaceuticals

FDA Regulatory Approval Process

Spotlight on Big Pharma

Neuropharmaceutical Partnering and Licensing

Neurology Markets

Alzheimer's Disease

Epilepsy and Siezure Disorders

Migraine

Mild Cognitive Impairment and AAMI

Multiple Sclerosis

Parkinson's Disease

Sleep Disorders

Stroke

Psychiatry Markets

Addiction

Anxiety Disorders

Attention Disorders

Depressive Disorders

Obesity

Schizophrenia

Sensory Markets

Retinal and Optic Nerve Disorders

Pain

4: Neurodevice Sector

Neurodevice Sector Overview

Neurodevice Markets

Neurodevice Sector Trends

FDA Classification and Approval Process

Medical Device Giants

Neuroprosthetic Devices

Cochlear Implants

Retinal Implants

Motor Prostheses & Brain-Computer Interface

Neuromodulation Devices

Neuromodulation clinical trials

Deep Brain Stimulation

Transcranial Magnetic Stimulation

Spinal Cord Stimulation

Vagus Nerve Stimulation

Peripheral Nerve Stimulation

Gastric Modulation and Obesity

Neurosurgical Devices

Neurosurgical Navigation Equipment

Radiosurgical Devices

Neurovascular Intervention

Neurosoftware

Attention Deficit Disorders

Pain Control

Age-related Disorders

5: Neurodiagnostic Sector

Neurodiagnostic Sector Overview

Neuroimaging

Computed Tomography (CT)

Magnetic Resonance Imaging (MRI, fMRI)

Nuclear Medicine Imaging (PET, SPECT)

Electroencephalography (EEG)

Magnetoencephalography (MEG)

In Vitro Diagnostics

Diagnostic Tests for Alzheimer's

Genetic Testing and Pharmacogenomics

Protein Biomarker Assays

Pattern Recognition in Diagnostics

Neuroinformatics

Patient Dataset Management

Open Source Software

6: Private Neurotech Investment

U.S. Venture Capital Investment 1999-2007

Neurotech Venture Capital 1999-2007

Largest Neurotech Investments 1999-2007

Leading Neurotech Venture Capital Firms

7: Public Neurotech Investment

Neurotech Initial Public Offerings 2004-Q12008

Neurotech M&A activity

Neuropharma Research and Licensing Deals

NeuroInsights' Neurotech Index

Neurotech Index Performance

8: Leading Research Centers

University of California, San Francisco (UCSF)

Massachusetts Institute of Technology (MIT)

University of California, San Diego (UCSD)

Harvard University

Stanford University

University of California, Los Angeles (UCLA)

Columbia University

University College London (UCL)

Karolinska Institutet, Stockholm

RIKEN Brain Science Institute, Japan

Places to Watch

9: Leading Neurotechnology Regions

The Global Neurotech Economy

Nexus Ranking and Methodology

Establish Neurotech Nexus'

Emerging Neurotech Nexus'

Nascent Neurotech Nexus'

Conclusions and Policy Recommendations

10: Company Profiles

Neuropharmaceutical Companies

Private

Public

Neurodevice Companies

Private

Public

Neurodiagnostic Companies

Private

Public

Abstract

The Neurotechnology Industry 2008 Report: Drugs, Devices and Diagnostics for the Brain and Nervous System

Now in its fourth year, The Neurotechnology Industry 2008 Report is an expanded and updated 400 page report of brain and nervous system markets and treatments. It is the only publication to provide a unified market-based framework to help investors, companies and entrepreneurs easily quantify opportunities, determine risks and understand the dynamics of rapidly changing CNS markets.

The report tracks advances in more than 16 indications at 500 companies including Alzheimer’s, addiction, anxiety, depressive disorders, epilepsy, migraine, mild cognitive impairment, multiple sclerosis, obesity, pain, Parkinson’s, schizophrenia, age-related macular degeneration, sensory disorders, sleep disorders, and stroke.

Report Highlights
The Neurotechnology Industry 2008 Report provides a unified market-based framework to help executives, investors, and governments easily quantify opportunities, determine risks and understand the dynamics of this rapidly growing market.

• 500 profiles of public and private neurotech companies including drugs, devices and diagnostics
• 12 most active neurotech venture capital firms profiled with investments by market segment and U.S. neurotech venture capital trends (1999-Q12008)
• Neurotech IPOs (2004-Q12008), M&A (2004-Q12008), Partnering and Licensing deals (2005-Q12008) and public neurotech stock performance
• 16 brain and nervous system illness markets analyzed including: addiction, Alzheimer's disease, anxiety, attention disorders, depression, epilepsy, hearing loss, insomnia, mild cognitive impairment, migraine, multiple sclerosis, obesity, pain, Parkinson's disease, retinal disorders, schizophrenia and stroke
• Analysis of biological basis, current treatment options, and emerging therapeutic strategies
• Analysis of compounds and devices in clinical trials by company, mechanis of action and stage of development for each indication
• Global and US market size, worldwide revenues for 2007
• Extensive discussion of specific technological, demographic, regulatory and intellectual property

Get Full Details About This Report >>

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.